FCH
ALXN

Freestone Capital Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Freestone Capital Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,018
Closed -$371K – 448
2021
Q2 		$371K Sell
2,018
-626
-24% -$107K 0.02% 308
2021
Q1 		$404K Sell
2,644
-7,916
-75% -$1.22M 0.02% 293
2020
Q4 		$1.65M Buy
10,560
+57
+0.5% +$7.33K 0.1% 170
2020
Q3 		$1.2M Sell
10,503
-274
-3% -$29.6K 0.08% 178
2020
Q2 		$1.21K Buy
10,777
+492
+5% +$52.2K 0.01% 188
2020
Q1 		$923 Buy
10,285
+1,257
+14% +$123K 0.02% 199
2019
Q4 		$976 Sell
9,028
-325
-3% -$34.8K 0.02% 265
2019
Q3 		$916 Buy
9,353
+494
+6% +$55.7K 0.02% 268
2019
Q2 		$1.16K Buy
8,859
+725
+9% +$93.4K 0.03% 223
2019
Q1 		$1.1M Buy
8,134
+3,776
+87% +$470K 0.07% 209
2018
Q4 		$424K Buy
4,358
+2,402
+123% +$284K 0.03% 311
2018
Q3 		$272K Buy
+1,956
New +$245K 0.02% 344

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return